BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14515662)

  • 1. [Correlation between menstruation disorders and insulin resistance].
    González Centeno A; Nahum Hernández P; Mendoza R; Ayala AR
    Ginecol Obstet Mex; 2003 Jun; 71():312-7. PubMed ID: 14515662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polycystic ovarian disease: clinical and biochemical expression].
    González Centeno A; Hernández Marín I; Mendoza R; Tovar Rodríguez JM; Ayala AR
    Ginecol Obstet Mex; 2003 May; 71():253-8. PubMed ID: 12908341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
    Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
    J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in adolescents with menstrual irregularities.
    Fernandes AR; de Sá Rosa e Silva AC; Romão GS; Pata MC; dos Reis RM
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):269-74. PubMed ID: 16171731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
    Mor E; Zograbyan A; Saadat P; Bayrak A; Tourgeman DE; Zhang C; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 2004 Jun; 190(6):1654-60. PubMed ID: 15284763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA
    Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian pathology associated with insulin resistance and acanthosis nigricans.
    Annos T; Taymor ML
    Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
    Abdel Fattah NS; Darwish YW
    Br J Dermatol; 2009 May; 160(5):1011-5. PubMed ID: 19298279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.